Skip to main content
SupplierTrail

Novacare, LLC

FEI 1000220648 · 2323 S 3600 W, West Valley City, Utah, 84119, United States

Per FDA, as of 2026-10-31 · Sources: FDA Data Dashboard, Import Alerts, Enforcement Reports

Get a dated evidence report for this supplierFree · for your supplier file · sample

Import alerts
0
Import refusals (5 years)
0
Warning letters
0
Last FDA action
2023-12-01
2 years ago
  1. 2023-12-01
    InspectionFDA inspection · Classification: No Action Indicated (NAI)
    Project area: Food Composition, Standards, Labeling and Econ
    FDA source
  2. 2018-05-09
    InspectionFDA inspection · Classification: Voluntary Action Indicated (VAI)
    Project area: Food Composition, Standards, Labeling and Econ
    FDA source
  3. 2017-04-10
    InspectionFDA inspection · Classification: Official Action Indicated (OAI)
    Project area: Food Composition, Standards, Labeling and Econ
    FDA source
  4. 2016-05-06
    InspectionFDA inspection · Classification: Voluntary Action Indicated (VAI)
    Project area: Food Composition, Standards, Labeling and Econ
    FDA source
  5. 2015-05-27
    RecallRecall F-2946-2015 · Class 2 · TSN Labs is conducting a field action on Glucosamine 750 mg 120 ct due to inadequate allergen labeling.
    Glucosamine 750 mg 120 ct, Capsule, Dosage: 12 capsules, 750 mg ea., three times daily with meals
    Source: FDA Enforcement Reports
  6. 2015-03-17
    InspectionFDA inspection · Classification: Official Action Indicated (OAI)
    Project area: Food Composition, Standards, Labeling and Econ
    FDA source
  7. 2015-03-02
    InspectionFDA inspection · Classification: Official Action Indicated (OAI)
    Project area: Food Composition, Standards, Labeling and Econ
    FDA source
  8. 2011-12-09
    InspectionFDA inspection · Classification: Voluntary Action Indicated (VAI)
    Project area: Food Composition, Standards, Labeling and Econ
    FDA source
  9. 2010-03-22
    InspectionFDA inspection · Classification: Official Action Indicated (OAI)
    Project area: Food Composition, Standards, Labeling and Econ
    FDA source